On April 26, 2022, the expedition ship Xuelong 2 for China’s 38th Antarctic expedition berthed at the Shanghai base dock.…
Browsing: Legend Capital
Legend Capital’s portfolio company Xbiome Inc., an industry-leading and AI-driven microbiome therapeutics company, recently announced that it acquired the clinical-stage…
Legend Capital’s portfolio company Lunit, a Korean Medical AI company, recently announced a preliminary approval from the Korea Exchange for…
Shanghai Langsheng Biotechnology Co., Ltd., a subsidiary of Legend Capital’s co-founded company Innostellar Biotherapeutics, announced that the clinical trial application…
On 31 March 2022, Legend Capital’s portfolio company Jiangsu Recbio Technology Co., Ltd. (Recbio, HKG: 2179), a leading novel vaccines…
On 28 February 2022, Inceptio Technology, an autonomous driving truck technology and operation company, announced its completion of a US$188…
On December 14, Legend Capital portfolio company SF Intra-city (09699.HK) successfully listed on the Hong Kong Stock Exchange (HKEx). SF…
Recently, Zhuhai Sailner 3D Technology Co., Ltd. (Sailner 3D), a leading industrial-grade color 3D printing company with independent core technology…
On November 15th, Aohua Endoscope (688212.SH), which invested by Legend Capital, was successfully listed on the Science and Technology Innovation…
On November 10th, TuringQ, China’s first photonic quantum computing company, announced its completion of a pre-A round of financing of…